Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg

Currently, interferon add-on therapy brings hope for clinical cure of chronic hepatitis B patients with low HBsAg. However, in clinical practice patients with poor responses to their first interferon therapy were often switched to nucleos(t)ide analog therapy and then labeled as unsuitable patients...

Full description

Bibliographic Details
Main Authors:	Xiaoan Yang, Ka Zhang, Qihuan Xu, Xin Shu, Zhishuo Mo, Dongying Xie, Zhiliang Gao, Hong Deng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	interferon add-on therapy clinical cure interferon-experienced patients chronic hepatitis B patients (CHB) HBsAg
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.997608/full

Similar Items

Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon
by: Peipei Wang, et al.
Published: (2023-01-01)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
by: Shaowen Jiang, et al.
Published: (2023-01-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
by: Minghui Li, et al.
Published: (2022-08-01)

Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue
by: Li-Li Wu, et al.
Published: (2023-06-01)

Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
by: Ekta Gupta, et al.
Published: (2023-12-01)

Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients
by: Yan L, et al.
Published: (2018-10-01)

Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Xiao Lin, et al.
Published: (2022-09-01)

Sero-prevalence of hepatitis B surface antigen (HBsAg), in sexually transmitted disease patients
by: N K D. Halim, et al.
Published: (2004-01-01)

The interferons : characterization and application /
by: Meager, Anthony
Published: (2006)

Clinical cure induced by pegylated interferon α-2b in the advantaged population of chronic hepatitis B virus infection: a retrospective cohort study
by: Chaojing Wen, et al.
Published: (2024-01-01)

Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function
by: Yisi Liu, et al.
Published: (2024-03-01)

Viral load in interferon treated & untreated patients of HCV
by: Alamzeb Jadoon, et al.
Published: (2023-08-01)

Interferons and interferon-related pathways in heart disease
by: Duc Tin Tran, et al.
Published: (2024-04-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Interferon : [electronic resource]: The 50th Anniversary/
by: 454129 Pitha, Paula M., et al.
Published: (2007)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Pegylated Interferons and Their Use in Clinical Practice
by: Alpay AZAP, et al.
Published: (2003-12-01)

THEORETICAL AND APPLIED ASPECTS OF THE INTERFERON SYSTEM: TO THE 60TH ANNIVERSARY OF THE DISCOVERY OF INTERFERONS
by: F. I. Ershov, et al.
Published: (2018-02-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort
by: Ta-Wei Liu, et al.
Published: (2018-01-01)

Clinical Utility of Quantitative Hbsag in Chronic Hepatitis B Infection
by: Poernomo Boedi Setiawan, et al.
Published: (2020-07-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression
by: Felix Hiebinger, et al.
Published: (2023-12-01)

HBsAg clearance and seroconversion case in a patient with HBeAg-negative chronic hepatitis B on pegylated interferon α-2a therapy
by: K. V. Zhdanov, et al.
Published: (2014-09-01)

Change of HBsAg Screening and Seropositivity in Pregnant Women By the Years
by: Gökhan TOSUN, et al.
Published: (2019-12-01)

Production of alpha-interferon in Lactococcus lactis
by: Bayat, Omid
Published: (2013)

HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases
by: Shuai Wu, et al.
Published: (2020-04-01)

Role of HBsAg Neutralisation Test in Low Positive and Indeterminate HBsAg Results by Electrochemiluminescence
by: Mridula Madiyal, et al.
Published: (2024-03-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection Neumonitis intersticial secundaria a tratamiento con interferón pegilado
by: J. Torres Macho, et al.
Published: (2010-10-01)

Erişkin HBsAg Pozitif Hastalarda Hepatit A Seroprevalansı
by: Alper Tahmaz, et al.
Published: (2020-09-01)

Screening of interferon-stimulated genes against avian reovirus infection and mechanistic exploration of the antiviral activity of IFIT5
by: Sheng Wang, et al.
Published: (2022-09-01)

Interferons lambda – therapeutic application
by: N. A. Kikhtenko, et al.
Published: (2020-05-01)

Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression
by: Caroline L. Ashley, et al.
Published: (2019-03-01)

Pestiviruses infection: Interferon-virus mutual regulation
by: Tianqi Hong, et al.
Published: (2023-03-01)

Epithelially Restricted Interferon Epsilon Protects Against ColitisSummary
by: Eveline D. de Geus, et al.
Published: (2024-01-01)

HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients
by: Bingqing Zheng, et al.
Published: (2021-07-01)

Interferon-λ Attenuates Rabies Virus Infection by Inducing Interferon-Stimulated Genes and Alleviating Neurological Inflammation
by: Yingying Li, et al.
Published: (2020-04-01)